Original Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2014; 20(1): 148-162
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.148
Table 5 CIGB-230 administration induces differential courses of cell-mediated immunity in virological responder and non-responder patients under therapy with interferon-α plus ribavirin
Immune responseHCV RNA (-) on week 48
HCV RNA (+) on week 48
HCV RNA (-) on week 72
HCV RNA (+) on week 72
Week 0Week 48P valueWeek 0Week 48P valueWeek 0Week 48P valueWeek 0Week 48P value
CIGB-230 immunized patients
IgGCore32193.315486.70.000122068.715130.5ns32193.315486.70.00322920.015130.50.0041
E2272.3103.50.006150295.3ns138.8103.1ns254.3138.7ns
NS38277.22969.1< 0.00017177.45555.50.0068013.12900.10.0027263.85555.50.0002
IFN-γCore69.215ns88.857.5ns68.818.3ns76.343.50.041
E217.45.6ns10.85.8ns22.55.2ns10.85.8ns
NS314.62.5ns38.816.3ns150ns26.315.1ns
SICore1.31ns1.41ns1.310.041.41ns
E210.90.00610.91.2ns10.8ns0.91.2ns
NS31.21ns0.90.9ns1.21.1ns1.10.9ns
Control patients
IgGCore26820.19096.30.001014778.910761.00.00828066.912800.00.00214778.98873.20.0005
E285.7233.1ns339.394.50.04085.7185ns339.3155ns
NS35150.32856.70.001015003.710833.1ns5150.32856.70.00315003.88577.9ns
IFN-γCore78.719.10.041060.315.6ns80.435ns60.3140.0200
E239.56.6ns50ns36.27.5ns32.52.5ns
NS335.94.10.031011.6ne-47.713ns12.94.2ns
SICore0.90.8ns1.20.8ns10.7ns1.11ns
E20.8a0.8ns1.8a1.4ns0.8c0.7ns1.4c1.4ns
NS30.80.8ns1.51.1ns0.80.7ns1.21.1ns

  • Citation: Amador-Cañizares Y, Martínez-Donato G, Álvarez-Lajonchere L, Vasallo C, Dausá M, Aguilar-Noriega D, Valenzuela C, Raíces I, Dubuisson J, Wychowski C, Cinza-Estévez Z, Castellanos M, Núñez M, Armas A, González Y, Revé I, Guerra I, Pérez Aguiar &, Dueñas-Carrera S. HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin. World J Gastroenterol 2014; 20(1): 148-162
  • URL: https://www.wjgnet.com/1007-9327/full/v20/i1/148.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v20.i1.148